News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DAVIS STEPHEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Exercised 103,999 shares
@ $0
Sold 51,563 shares
@ $21.96, valued at
$1.1M
Exercised 103,999 restricted stock units
@ $0 |
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 16,498 shares
@ $25, valued at
$412.5k
Sold 55,104 shares
@ $25.0517, valued at
$1.4M
|
|
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 295,503 options to buy
@ $21.75, valued at
$6.4M
Granted 89,564 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 7,806 shares
@ $21.18, valued at
$165.3k
Exercised 15,625 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 3,851 shares
@ $18.78, valued at
$72.3k
Exercised 10,945 restricted stock units
@ $0 |
|
| 01/10/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 3,904 shares
@ $17.1303, valued at
$66.9k
Exercised 9,528 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 74,739 shares
@ $0 |
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 43,400 shares
@ $0 |
|
| 06/16/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 15,000 options to buy
@ $1.11, valued at
$16.7k
|
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 237,931 options to buy
@ $25.75, valued at
$6.1M
Granted 69,333 restricted stock units
@ $0
Granted 277,331 restricted stock units
@ $0 |
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 3,718 shares
@ $23.05, valued at
$85.7k
Exercised 9,527 restricted stock units
@ $0 |
|
| 01/06/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 18,715 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 10,452 shares
@ $0
Granted 20,903 options to buy
@ $9.81, valued at
$205.1k
|
|
| 10/19/2021 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 2,963 shares
@ $17.41, valued at
$51.6k
Exercised 5,938 restricted stock units
@ $0 |
|
| 07/07/2021 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 3,000 shares
@ $0
Granted 18,000 options to buy
@ $19.46, valued at
$350.3k
|
|
| 10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $8.42, valued at
$54.7k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2020 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 6,770 shares
@ $49.21, valued at
$333.2k
Exercised 15,625 restricted stock units
@ $0 |
|
| 04/17/2020 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 1,426 options to buy
@ $14.44, valued at
$20.6k
|
|
|
|
|